Compare LITE & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITE | EXAS |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1B | 19.7B |
| IPO Year | 2015 | 2000 |
| Metric | LITE | EXAS |
|---|---|---|
| Price | $682.62 | $103.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 17 |
| Target Price | ★ $574.31 | $86.62 |
| AVG Volume (30 Days) | ★ 4.5M | 1.9M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.56 | 80.32 |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $1,247,700,000.00 | $4,144,000.00 |
| Revenue This Year | $78.72 | $15.37 |
| Revenue Next Year | $56.97 | $12.41 |
| P/E Ratio | $560.70 | ★ N/A |
| Revenue Growth | ★ 24.57 | N/A |
| 52 Week Low | $45.66 | $38.88 |
| 52 Week High | $780.00 | $103.87 |
| Indicator | LITE | EXAS |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 58.57 |
| Support Level | $135.23 | $102.95 |
| Resistance Level | $780.00 | $103.77 |
| Average True Range (ATR) | 53.01 | 0.31 |
| MACD | -13.39 | -0.07 |
| Stochastic Oscillator | 58.97 | 48.13 |
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.